Impact of lack of knowledge on risk perception and protective practices of home nurses handling antineoplastic drugs

Abstract

Introduction: Health care workers handling antineoplastic drugs (ADs) are at risk of carcinogenic, mutagenic and reproductive toxic risks (CMR). The aim of this study was to assess the impact of the lack of knowledge (K) on risk perception (P) and on protective practices (PP) related to the handling of home-based chemotherapy (HC) by home nurses. Methods: This study was conducted in Normandy among home nurses. A questionnaire was developed to explore the K, P and PP related to handling ADs by home nurses working with four different providers from two hospitals. Results: Among the 28 home nurses included, 25.93% had received initial training on the specific treatment of ADs, 48.15% scored below average on risk management K, 52.00% scored below average on personal PP. Conclusion: This study reveals the importance of adapted and regular training on the handling of ADs. It will help develop a climate of safety and reinforce adherence to wearing personal protective equipment to protect health care workers from contamination.

Keywords

Chemotherapy cancer program safety education home nurses occupational exposure knowledge handling practices training

Get full access to this article

View all access options for this article.

References

Falck

Gröhn

Sorsa

, et al. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1979; 313: 1250–1251.

Occupational Safety and Health Administration. Controlling occupational exposure to hazardous drugs. Am J Health-Syst Pharm 1996; 53: 1669–1685.

National Institute for Occupational Safety and Health. NIOSH alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health. www.cdc.gov/niosh/docs/2004-165/ (2004, accessed May 2022).

Power

Coyne

. ASHP Guidelines on handling hazardous drugs. Am J Health-Syst Pharm 2018; 75: 1996–2031.

Oncology Nursing Society. Clinical guide to antineoplastic therapy: A chemotherapy handbook. Oncology Nursing Society (2020, accessed May 2022).

The United States pharmacopeia: General Chapter Hazardous Drugs. Handling in healthcare settings. https://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare (2020, accessed May 2022).

International Society of Oncology Pharmacy Practitioners. Standards of practice. Safe handling of cytotoxics. https://kutmedya.com/korulu/documents/isopp.pdf (2007, accessed May 2022).

Agence Nationale de Sécurité Sanitaire de L'alimentation de L'environnement et du Travail. Travaux exposant aux cytostatiques. https://www.anses.fr/fr/system/files/VSR2017SA0237Ra.pdf (2021, accessed May 2022).

Chavis-Parker

. Safe chemotherapy in the home environment. Home Healthc Now 2015; 33: 246–251.

10.

Benoist

Breuil

Le Neindre

, et al.

Does equipment change impact blood contamination with irinotecan and its two major metabolites in a centralized cytotoxic pharmacy unit?

J Oncol Pharm Pract 2020; 26: 1823–1828.

11.

Béchet

Benoist

Beau

, et al. Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit. J Oncol Pharm Pract 2022; 28: 777–784.

12.

Delafoy

Benoist

Patin

, et al. Knowledge and practices about safe handling regarding the risk of exposure to antineoplastic drugs for caregivers in compounding units and in operating rooms performing HIPEC/PIPAC. J Oncol Pharm Pract 2022; 13: 10781552221144303.

13.

Pirot

Benoist

Lagadu

, et al. Impact of low- and high-risk caregivers and non-caregivers handling irinotecan on blood contamination in oncology day hospital units. J Oncol Pharm Pract 2022; 5: 10781552221090965.

14.

Benoist

Busson

Faveyrial

, et al. Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff. J Oncol Pharm Pract 2022; 29: 10781552221103803.

15.

Yuki

Sekine

Takase

, et al. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients. J Oncol Pharm Pract 2013; 19: 208–217.

16.

Benoist

Eveno

Wilson

, et al. Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC. Pleura Peritoneum 2022; 7: 77–86.

17.

Delafoy

Benoist

Vasseur

, et al. Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units. J Oncol Pharm Pract 2023. DOI: 10.1177/10781552231156520.

18.

Hon

Abusitta

. Causes of health care workers’ exposure to antineoplastic drugs: an exploratory study. Can J Hosp Pharm 2016; 69: 216–223.

19.

Hon

Teschke

Shen

. Health care workers’ knowledge, perceptions, and behaviors regarding antineoplastic drugs: survey from British Columbia, Canada. J Occup Environ Hyg 2015; 12: 669–677.

20.

Boiano

Steege

Sweeney

. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg 2014; 11: 728–740.

21.

Geer

Anna

Curbow

, et al. Survey assessment of worker dermal exposure and underlying behavioral determinants. J Occup Environ Hyg 2007; 4: 809–820.

22.

Dejoy

Smith

Woldu

, et al. Effects of organizational safety practices and perceived safety climate on PPE usage, engineering controls, and adverse events involving liquid antineoplastic drugs among nurses. J Occup Environ Hyg 2017; 14: 485–493.

23.

Hennessy

Dynan

. Improving compliance with personal protective equipment use through the model for improvement and staff champions. Clin J Oncol Nurs 2014; 18: 497–500.

24.

Clark

Zickar

Jex

. Role definition as a moderator of the relationship between safety climate and organizational citizenship behavior among hospital nurses. J Bus Psychol 2014; 29: 101–110.

25.

Rudnitzki

McMahon

. Oral agents for cancer: safety challenges and recommendations. Clin J Oncol Nurs 2015; 19: 41–46.

26.

Mendelsohn-Victor

McCullagh

, et al. Personal protective equipment use and hazardous drug spills among ambulatory oncology nurses. Oncol Nurs Forum 2017; 44: 60–65.

27.

Huff

. Hazardous drug residues in the home setting: worker safety concerns. J Infus Nurs 2020; 43: 15–18.

28.

Böhlandt

Sverdel

Schierl

. Antineoplastic drug residues inside homes of chemotherapy patients. Int J Hyg Environ Health 2017; 220: 757–765.

29.

Crickman

Finnell

. Systematic review of control measures to reduce hazardous drug exposure for health care workers. J Nurs Care Qual 2016; 31: 183–190.

30.

Evans

Qiu

MacKinnon

, et al. A multi-method review of home-based chemotherapy. Eur J Cancer Care 2016; 25: 883–902.

31.

Polovich

Clark

. Factors influencing oncology nurses’ use of hazardous drug safe-handling precautions. Oncol Nurs Forum 2012; 39: 299–309.

32.

National Institute for Occupational Safety and Health. Workplace solutions: Personal protective equipment for health care workers who work with hazardous drugs. https://www.cdc.gov/niosh/docs/wp-solutions/2009-106/pdfs/2009-106.pdf. (2008, accessed May 2022).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.23 MB